Keeping Track: US FDA Acts On 5 Novel Drugs: Approval For Fotivda, Pepaxto, Azstarys; CRLs For Defencath and Oral Paclitaxel

 
• By Bridget Silverman

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker

Keeping Track Feature image

More from Approvals

More from Product Reviews